| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,470 | 18,528 | 15,562 | 15,674 | | Cost of Revenue | 15,157 | 13,817 | 10,931 | 11,365 | | | Gross Profit | 5,313 | 4,711 | 4,631 | 4,309 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,733 | 5,302 | 5,041 | 4,900 | | Non Recurring |
-
|
-
|
-
| 7,477 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (420) | (592) | (409) | (8,067) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (420) | (592) | (409) | (8,067) | | Interest Expense | 687 | 362 | 309 | 352 | | Income Before Tax | (1,107) | (953) | (719) | (8,419) | | Income Tax Expense | (331) | (379) | (122) | (2,954) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (776) | (574) | (597) | (5,465) | | | Non-recurring Events | | Discontinued Operations |
-
| 9 | (9) | 36 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (776) | (565) | (606) | (5,429) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($776) | ($565) | ($606) | ($5,429) |
|
0.51% Nasdaq 
Income Statement
